POTENTIAL FOR INTENSITY-MODULATED RADIATION THERAPY TO PERMIT DOSE ESCALATION FOR CANINE NASAL CANCER

Authors

  • CATHERINE VAUDAUX,

    1. Section of Diagnostic Imaging and Radio-Oncology, Vetsuisse-Faculty University of Zürich, Winterthurerstrasse 260, 8057 Zürich, Switzerland
    Search for more papers by this author
  • UWE SCHNEIDER,

    1. Clinic for Nuclearmedicine and Radio-Oncology, City Hospital Triemli, Birsmendorferstrasse 497, 8063 Zürich, Switzerland.
    Search for more papers by this author
  • BARBARA KASER-HOTZ

    1. Section of Diagnostic Imaging and Radio-Oncology, Vetsuisse-Faculty University of Zürich, Winterthurerstrasse 260, 8057 Zürich, Switzerland
    Search for more papers by this author

  • This work was conducted in the context of a doctoral thesis (C.Vaudaux)

Address correspondence and reprint requests to Catherine Vaudaux at the above address. E-mail: cvaudaux@vetclinics.unizh.ch

Abstract

We evaluated the impact of inverse planned intensity-modulated radiation therapy (IMRT) on the dose–volume histograms (DVHs) and on the normal tissue complication probabilities (NTCPs) of brain and eyes in dogs with nasal tumors. Nine dogs with large, caudally located nasal tumors were planned using conventional techniques and inverse planned IMRT for a total prescribed dose of 52.5 Gy in 3.5 Gy fractions. The equivalent uniform dose for brain and eyes was calculated to estimate the normal tissue complication probability (NTCP) of these organs. The NTCP values as well as the DVHs were used to compare the treatment plans. The dose distribution in IMRT plans was more conformal than in conventional plans. The average dose delivered to one-third of the brain was 10 Gy lower with the IMRT plan compared with conventional planning. The mean partial brain volume receiving 43.6 Gy or more was reduced by 25.6% with IMRT. As a consequence, the NTCPs were also significantly lower in the IMRT plans. The mean NTCP of brain was two times lower and at least one eye could be saved in all patients planed with IMRT. Another possibility with IMRT is dose escalation in the target to improve tumor control while keeping the NTCPs at the same level as for conventional planning.

Ancillary